Second Wave Cancer Immunotherapy and Combination Strategies
September 16, 2017
Shanghai, China
Peking University
Finnegan partner Li Feng will join the panel discussion "Patent/IP Challenges in IO Agent Development" at Peking University’s International Symposium, Second Wave Cancer Immunotherapy and Combination Strategies. The program will take place at the ZTE Hotel in Shanghai, China. For more information, or to register, please see Peking University's website.
